Literature DB >> 3143036

Purification and some properties of a Vero toxin from Escherichia coli O157:H7 that is immunologically unrelated to Shiga toxin.

T Yutsudo1, N Nakabayashi, T Hirayama, Y Takeda.   

Abstract

A cytotoxin to Vero cells (Vero toxin) was purified from Escherichia coli O157:H7 isolated from a patient with hemorrhagic colitis by ammonium sulfate fractionation, DEAE-cellulose column chromatography, repeated chromatofocusing column chromatography and repeated high performance liquid chromatography. About 440 micrograms of purified Vero toxin was obtained from 12 liters of culture with a yield of about 22%. The purified Vero toxin showed similar cytotoxic activity to that of Shiga toxin to Vero cells and killed about 50% of the Vero cells at 1 pg. The activity was lost on heating the toxin at 80 degrees C for 10 minutes, but not at 60 degrees C for 10 minutes. The toxin also showed lethal toxicity to mice when injected intraperitoneally, the LD50 being 1 ng per mouse. The purified Vero toxin consisted of A and B subunits with molecular weights of about 35,000 and 10,700, respectively, which were slightly larger than those of Shiga toxin. On polyacrylamide gel disc electrophoresis, the mobility of the purified Vero toxin differed from that of Shiga toxin. The isoelectric point of the toxin was 4.1, which was also different from that of Shiga toxin (pI = 7.0). Furthermore, Vero toxin and Shiga toxin were found to be immunologically unrelated; anti-Vero toxin did not react with Shiga toxin, and similarly anti-Shiga toxin did not react with the Vero toxin in either the Ouchterlony double gel diffusion test or enzyme-linked immunosorbent assay. The Vero toxin purified in this work was found to be immunologically identical to VT2 and Shiga-like toxin II reported previously.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3143036     DOI: 10.1016/0882-4010(87)90034-9

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  36 in total

1.  Effects of Shiga toxin 2 on lethality, fetuses, delivery, and puerperal behavior in pregnant mice.

Authors:  K Yoshimura; J Fujii; A Tanimoto; T Yutsudo; M Kashimura; S Yoshida
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

2.  Toxicity of Shiga toxin 1 in the central nervous system of rabbits.

Authors:  J Fujii; Y Kinoshita; T Yutsudo; H Taniguchi; T Obrig; S I Yoshida
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

3.  Shiga toxin 2 induces macrophage-granulocyte colonies from human bone marrow and cord blood stem cells.

Authors:  Shin Chiyoda; Tae Takeda; Yosuke Aoki
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

4.  Genome analysis of a novel Shiga toxin 1 (Stx1)-converting phage which is closely related to Stx2-converting phages but not to other Stx1-converting phages.

Authors:  Toshio Sato; Takeshi Shimizu; Masahisa Watarai; Midori Kobayashi; Shigeyuki Kano; Takashi Hamabata; Yoshifumi Takeda; Shinji Yamasaki
Journal:  J Bacteriol       Date:  2003-07       Impact factor: 3.490

5.  Identification and characterization of a newly isolated shiga toxin 2-converting phage from shiga toxin-producing Escherichia coli.

Authors:  M Watarai; T Sato; M Kobayashi; T Shimizu; S Yamasaki; T Tobe; C Sasakawa; Y Takeda
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

6.  Purification and characterization of an Escherichia coli Shiga-like toxin II variant.

Authors:  D L MacLeod; C L Gyles
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

7.  Protection by a recombinant Mycobacterium bovis Bacillus Calmette-Guerin vaccine expressing Shiga toxin 2 B subunit against Shiga toxin-producing Escherichia coli in mice.

Authors:  Jun Fujii; Mariko Naito; Takashi Yutsudo; Sohkichi Matsumoto; Daniel P Heatherly; Takeshi Yamada; Hideyuki Kobayashi; Shin-Ichi Yoshida; Tom Obrig
Journal:  Clin Vaccine Immunol       Date:  2012-10-03

8.  Direct evidence of neuron impairment by oral infection with verotoxin-producing Escherichia coli O157:H- in mitomycin-treated mice.

Authors:  J Fujii; T Kita; S Yoshida; T Takeda; H Kobayashi; N Tanaka; K Ohsato; Y Mizuguchi
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

9.  Evaluation of oligonucleotide probes for identification of shiga-like-toxin-producing Escherichia coli.

Authors:  H Karch; T Meyer
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

10.  The specific activities of Shiga-like toxin type II (SLT-II) and SLT-II-related toxins of enterohemorrhagic Escherichia coli differ when measured by Vero cell cytotoxicity but not by mouse lethality.

Authors:  S W Lindgren; J E Samuel; C K Schmitt; A D O'Brien
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.